Tolerability of Shortened Infliximab Infusion Times in Patients With Inflammatory Bowel Diseases: A Single-Center Cohort Study (Q57265368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

25 January 2020

main subject

inflammation

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Kristel Van Steen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Séverine Vermeire

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

2

Marc Ferrante

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

8

Paul Rutgeerts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

5

Maja Noman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

3

Herma Fidder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Vera Ballet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Gert Van Assche

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

15 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

778-785

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Long-term outcome after infliximab for refractory ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

The safety of infliximab infusions in the community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.61

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21407184%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference